Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.11B |
| 2 |
Vale
VALE
|
+$929M |
| 3 |
Microsoft
MSFT
|
+$877M |
| 4 |
Comcast
CMCSA
|
+$830M |
| 5 |
Mercado Libre
MELI
|
+$795M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.91B |
| 2 |
AbbVie
ABBV
|
+$1.89B |
| 3 |
Broadcom
AVGO
|
+$1.22B |
| 4 |
UnitedHealth
UNH
|
+$1.01B |
| 5 |
United Parcel Service
UPS
|
+$938M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.95% |
| 2 | Healthcare | 15.55% |
| 3 | Communication Services | 13.77% |
| 4 | Consumer Discretionary | 13.24% |
| 5 | Financials | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Advanced Micro Devices
AMD
$811B
| $768M | 0.19% |
9,783,828
+3,536,546
| +57% | +$305M |
|
127
Wyndham Hotels & Resorts
WH
$5.48B
| $737M | 0.18% |
10,568,090
-455,212
| -4% | -$29.1M |
|
|
ALLK
128
DELISTED
Allakos
ALLK
| $729M | 0.18% |
6,347,530
+8,563
| +0.1% | +$1.08M |
|
129
Omnicom Group
OMC
$23.7B
| $721M | 0.18% |
9,725,184
+1,006,574
| +12% | +$69.5M |
|
130
Edwards Lifesciences
EW
$53.8B
| $709M | 0.17% |
8,472,377
-1,786,094
| -17% | -$151M |
|
131
Petrobras Class A
PBR.A
$103B
| $706M | 0.17% |
82,695,252
-2,535,656
| -3% | -$24.1M |
|
132
Haemonetics
HAE
$4.16B
| $690M | 0.17% |
6,217,498
+579,763
| +10% | +$71.7M |
|
133
SS&C Technologies
SSNC
$18.8B
| $688M | 0.17% |
9,840,360
-883,427
| -8% | -$59.7M |
|
134
Sherwin-Williams
SHW
$87.2B
| $685M | 0.17% |
2,783,520
+91,155
| +3% | +$21.7M |
|
135
XP
XP
$8.04B
| $678M | 0.17% |
18,006,389
-1,666,135
| -8% | -$71.1M |
|
|
136
United Parcel Service
UPS
$89.4B
| $676M | 0.17% |
3,976,713
-5,796,873
| -59% | -$938M |
|
137
Marriott International
MAR
$92.6B
| $631M | 0.15% |
4,257,626
+320,315
| +8% | +$43.7M |
|
138
Southern Company
SO
$107B
| $614M | 0.15% |
9,876,800
+929,207
| +10% | +$55.6M |
|
139
Sarepta Therapeutics
SRPT
$1.95B
| $598M | 0.15% |
8,026,903
+290,155
| +4% | +$26.8M |
|
140
Costco
COST
$422B
| $597M | 0.15% |
1,692,457
-1,226,698
| -42% | -$427M |
|
141
Melco Resorts & Entertainment
MLCO
$2.15B
| $590M | 0.14% |
29,623,173
+187,242
| +0.6% | +$3.55M |
|
142
Intel
INTC
$540B
| $577M | 0.14% |
9,009,004
-2,540,435
| -22% | -$151M |
|
143
D.R. Horton
DHI
$41.5B
| $576M | 0.14% |
6,458,281
-314,177
| -5% | -$24.6M |
|
144
CrowdStrike
CRWD
$227B
| $573M | 0.14% |
12,548,148
+1,453,928
| +13% | +$76.9M |
|
145
Integra LifeSciences
IART
$1.44B
| $569M | 0.14% |
8,230,231
-7,050
| -0.1% | -$478K |
|
146
Applied Materials
AMAT
$443B
| $565M | 0.14% |
+4,227,742
| New | +$466M |
|
147
Otis Worldwide
OTIS
$27.7B
| $558M | 0.14% |
8,153,134
-763,189
| -9% | -$49.9M |
|
148
Enbridge
ENB
$112B
| $548M | 0.13% |
15,048,932
+3,028,314
| +25% | +$106M |
|
|
BLD
149
DELISTED
TopBuild
BLD
| $542M | 0.13% |
2,587,145
+414
| +0% | +$84.1K |
|
150
NVR
NVR
$17B
| $534M | 0.13% |
113,403
+7,532
| +7% | +$33.8M |
|
Similar funds
Capital Research Global Investors's Q1 2021 Portfolio in Review
As of Q1 2021, Capital Research Global Investors held 447 positions worth $409B, up 6.1% from $385B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors's Q1 2021 filing shows 43 new, 191 increased, 149 reduced and 22 closed positions. Its largest new stake was Applied Materials: 4,227,742 shares worth $565M. The largest sale was Meta Platforms (Facebook), an estimated $2.91B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Communication Services.
- Capital Research Global Investors's largest Q1 2021 buy was Applied Materials: 4,227,742 shares worth $565M.
- Capital Research Global Investors added most to JPMorgan Chase in Q1 2021, an estimated $1.11B increase.
- Capital Research Global Investors's biggest Q1 2021 reduction was Meta Platforms (Facebook), cutting an estimated $2.91B.
- Capital Research Global Investors fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $532M.
- Capital Research Global Investors's ten largest holdings make up 29% of its $409B portfolio in Q1 2021.
- Capital Research Global Investors opened 43 new positions and closed 22 in Q1 2021.
- Capital Research Global Investors's portfolio value rose 6.1% quarter-over-quarter to $409B.
Based on Capital Research Global Investors's 13F filing for Q1 2021, filed 14 May 2021.